BlinkLab Limited (ASX:BB1)

Australia · Delayed Price · Currency is AUD

0.6850

-0.0150 (-2.14%)

Jul 8, 2026, 4:10 PM AEST

34.31% (1Y)

Market Cap	104.72M +91.6%
Revenue (ttm)	375.82K +92.9%
Net Income	-7.24M
EPS	-0.07
Shares Out	152.87M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	46,484
Open	0.6700
Previous Close	0.7000
Day's Range	0.6550 - 0.6850
52-Week Range	0.4050 - 1.1050
Beta	1.32
Analysts	Buy
Price Target	1.83 (+167.15%)
Earnings Date	Aug 28, 2026

About BlinkLab

BlinkLab Limited focuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing. Its smartphone-based application serves as a device for conducting neurobehavioral evaluations. The company’s application also enables remote and rapid testing to aid research on neurodevelopmental and neurodegenerative conditions such as schizophrenia, autism, attention deficit hyperactivity disorder (ADHD), and various forms of dementia. The company was incorporated in 2021 and is based in Perth, Australia. [Read more]

Industry Health Information Services

Sector Healthcare

Founded 2021

Country Australia

Stock Exchange Australian Securities Exchange

Ticker Symbol BB1

Full Company Profile

Financial Performance

In fiscal year 2025, BlinkLab's revenue was 375,551, an increase of 916.07% compared to the previous year's 36,961. Losses were -5.71 million, 225.5% more than in 2024.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for BB1 stock is "Buy." The 12-month stock price target is $1.83, which is an increase of 167.15% from the latest price.

Price Target

$1.83

(167.15% upside)

Analyst Consensus: Buy

Stock Forecasts